UK manufacturing begins to rebuild

Likewise plc

UK manufacturing output rose in October for the first time in over a year, marking a shift that has largely gone unnoticed. The sector has spent much of the past 18 months under pressure, weighed down by weak demand, high input costs, and persistent uncertainty. But the latest signals suggest those conditions are beginning to ease. The official purchasing managers’ index moved to a twelve-month high of 44.8 in October, still below the 50 mark, but moving in the right direction and at its strongest level in a year.

More notably, the uptick in output was broad-based across several categories. Transport, machinery, and consumer goods producers all reported month-on-month increases. Manufacturers also cited early signs of improving orders, both at home and abroad, even if export volumes remain uneven. With inventories normalising and supply chain disruption largely resolved, many firms have shifted focus back to production, which has begun to feed into output data.

Confidence among manufacturers is also strengthening. Business expectations are now at their highest since early 2022, supported by better order visibility and a more stable input cost environment. Energy prices, which had been a major drag in the previous winter, have moderated, giving firms more breathing room on margins. With pricing power still limited, the relief on cost pressure is material and timely.

Likewise Group PLC (LON:LIKE) is a distributor of floorcoverings and matting and has the opportunity to consolidate the domestic and commercial floorcovering markets to become one of the UK’s largest distributors in this sector.

Share on:

Latest Company News

PPHE Hotel Group refinances Park Plaza Victoria London

PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026.

Greggs Plc appoints Richard Smothers as Non-Executive Director

Greggs plc has announced the appointment of Richard Smothers as an independent Non-Executive Director, effective from 1 February 2026.

Hollywood Bowl Group reports FY2025 results with revenue growth

Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue and adjusted EBITDA.

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy.

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer.

GSK Plc secures UK approval for Exdensur in asthma and nasal polyps

GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients.

    Search

    Search